AvevoRx Further Expands Midwest Service Area to Include Kansas, North Dakota

The independent specialty infusion pharmacy continues a pace of rapid growth to serve patients facing chronic, complex conditions in 30 states

GREENSBORO, N.C., March 12, 2024 /PRNewswire-PRWeb/ -- AvevoRx, a national, independent provider of specialty infusion pharmacy services, has expanded its Midwest service area to include Kansas and North Dakota, adding to its growing national footprint. The news follows the company's expansion into South Dakota, announced earlier this year. AvevoRx is now licensed to treat patients in 30 states nationwide, over 73 percent of the U.S. population.

The Center for Disease Control and Prevention's (CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) estimates that six in ten Americans live with at least one chronic disease, and an estimated 4 in 10 live with multiple. Such ailments are the leading causes of death and disability in the U.S. and a primary driver of rising healthcare costs.

"By expanding to as many states as possible, we can help ensure greater access to specialty infusion treatments and services for more patients," said Courtney Remley, AvevoRx co-founder and head of Eastern U.S. sales. "We understand that infusions administered at home or in specialty infusion centers offer folks a more cost-effective, comfortable treatment alternative. We are fortunate to be in a position of steadily growing our service area so we can do more for more people."

A truly national provider, AvevoRx expects its geographic expansion to continue throughout the U.S. well into 2024. The company has far outpaced typical market expectations through a mix of organic growth and strategic acquisitions since its inception.

AvevoRx began as a startup in Greensboro, North Carolina, founded in 2021 by a team of industry veterans with 130 years of combined experience. By November of that year, it acquired Mid Valley Health Services, a long-established infusion company based near Modesto, CA. In September 2022, AvevoRx entered an agreement to acquire Access to Care, LLC, an independent home infusion pharmacy in Muncie, IN. Today, both companies operate under the AvevoRx name.

Justin Dent, National Director of Pharmacy Operations for AvevoRx, adds, "Each expansion brings us greater reach across much of the country while we zero in on areas with the greatest need for our services. As we grow, we establish new processes and operations built on our core principles of speed, service, and simplicity to help scale our high-touch, high-service model."

To refer a patient or to get more information on the specialty infusion solutions provided by AvevoRx, call us at 877-AvevoRx or contact us through our website. Learn more at AvevoRx.com.

About AvevoRx

AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.

Media Contact

Victoria Seremeta, AvevoRx, 1 5162861950, [email protected], www.avevorx.com

SOURCE AvevoRx